title: [Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder].
authors.affiliation: Centre Eugène-Marquis, Rennes.
authors.forename: Patrick
authors.initials: P
authors.lastname: Bourguet
authors.forename: François
authors.initials: F
authors.lastname: Planchamp
authors.forename: Françoise
authors.initials: F
authors.lastname: Montravers
authors.forename: Sébastien
authors.initials: S
authors.lastname: Vincendeau
authors.forename: Frédéric
authors.initials: F
authors.lastname: Courbon
authors.forename: Véronique
authors.initials: V
authors.lastname: Edeline
authors.forename: Badia-Ourkia
authors.initials: BO
authors.lastname: Helal
authors.forename: Dominique
authors.initials: D
authors.lastname: Rossi
authors.forename: Arnauld
authors.initials: A
authors.lastname: Villers
mesh_terms: D005260:Female; D005602:France; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D049268:Positron-Emission Tomography / Q000379:methods*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging*; D019275:Radiopharmaceuticals; D013736:Testicular Neoplasms / Q000000981:diagnostic imaging*; D001749:Urinary Bladder Neoplasms / Q000000981:diagnostic imaging*
chemical_list: D019275:Radiopharmaceuticals